Takeda Pharmaceutical (TAK) Inventory Average (2018 - 2026)

Takeda Pharmaceutical's Inventory Average history runs 9 years deep, the most recent figure standing at $9.0 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 11.57% year-over-year to $9.0 billion; the TTM figure through Mar 2026 stood at $9.0 billion (up 11.57% YoY), while the FY2026 annual figure was $8.6 billion, up 5.42% from the prior year.
• Inventory Average was $9.0 billion for Q1 2026 at Takeda Pharmaceutical, roughly flat from $9.0 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $9.0 billion in Q1 2026 to a low of $6.7 billion in Q4 2022.
• Historically, Inventory Average has averaged $7.9 billion across 5 years, with a median of $8.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average dropped 5.52% in 2022, then increased 18.19% in 2023.
• A 5-year view of Inventory Average shows it stood at $6.7 billion in 2022, then climbed by 18.19% to $8.0 billion in 2023, then grew by 2.33% to $8.1 billion in 2024, then advanced by 10.29% to $9.0 billion in 2025, then gained by 0.48% to $9.0 billion in 2026.
• The last three Inventory Average figures came in at $9.0 billion (Q1 2026), $9.0 billion (Q4 2025), and $8.7 billion (Q3 2025), per Business Quant data.